BioCorRx (BICX) EBITDA Margin (2011 - 2026)
BioCorRx (BICX) posted EBITDA Margin of 445.61% for Q1 2026, up 75.98% sequentially from 1854.91% in Q4 2025, and up 24969.0% YoY from N/an in Q1 2025.
Powered by 
Analysis
BioCorRx (BICX) EBITDA Margin (2011 - 2026) Analysis & Trends
BioCorRx has reported EBITDA Margin for 16 years, with the latest figure at 445.61% in Q1 2026.
- Quarterly EBITDA Margin rose 24969.0% year-over-year to 445.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 554.74% (up 310988.0% YoY) and the FY2025 annual result came in at 606.04%, up 6622377.0% from the prior year.
- EBITDA Margin climbed to 445.61% in Q1 2026 per BICX's latest filing, from 1854.91% in the prior quarter.
- Over five years, EBITDA Margin peaked at 28.38% in Q3 2025 and troughed at 33852.95% in Q2 2024.
- A 5-year average of 6808.24% and a median of 2611.93% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin tumbled 2903044 bps in 2024, then surged 3305968 bps in 2025.
- Over 5 years, EBITDA Margin stood at 1430.79% in 2022, then sank by 204 bps to 4344.24% in 2023, then sank by 679 bps to 33852.95% in 2024, then jumped by 95 bps to 1854.91% in 2025, then soared by 76 bps to 445.61% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 445.61%, 1854.91%, and 28.38% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -12.60% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 26.67% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 2.10% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 16.29% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 11.14% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 8.50% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 15.37% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 7.66% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 18.99% |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -444.39% |
| Dec 31, 2025 | 348.91% |
| Sep 30, 2025 | -306.05% |
| Jun 30, 2025 | -790.96% |
| Mar 31, 2025 | -692.50% |
| Jun 30, 2024 | -33,694.26% |
| Mar 31, 2024 | -26,582.13% |
| Dec 31, 2023 | -4,310.34% |
| Sep 30, 2023 | -9,417.93% |
| Jun 30, 2023 | -4,789.82% |
| Mar 31, 2023 | -2,596.17% |
| Dec 31, 2022 | -1,422.86% |
| Sep 30, 2022 | -1,082.75% |
| Jun 30, 2022 | -8,447.62% |
| Mar 31, 2022 | -5,449.39% |
| Dec 31, 2021 | -9,742.67% |
| Sep 30, 2021 | -18,464.17% |
| Jun 30, 2021 | -6,072.28% |
| Mar 31, 2021 | -15,543.59% |
| Dec 31, 2020 | -7,918.14% |